key: cord-1027672-fuy10fqc
authors: Antonoff, Mara B.
title: Commentary: Collaboration is Key to Saving as Many Lives as Possible
date: 2020-05-01
journal: J Thorac Cardiovasc Surg
DOI: 10.1016/j.jtcvs.2020.04.069
sha: 5ce230f645e9bc971f281bfc65cfb8dddb0e0486
doc_id: 1027672
cord_uid: fuy10fqc

nan

In this issue, Dr. Chen and colleagues share insights from the Chinese experience with the 1 coronavirus, for the benefit of improving thoracic surgical outcomes worldwide during this 2 unprecedented time. 1 This article is certainly quite timely, and, at this moment, the information 3 shared is likely of greater relevance to the majority of surgeons in our field than any other 4 previous publication. This pandemic affects us all-all of our practices, all of our patients, all of 5 our colleagues and communities. Based on Peng's cohort study of perioperative COVID-19 6 outcomes 2 , as well as additional experience from the Chinese thoracic surgical workforce, the 7 authors of this paper share wisdom in attempts to lessen the global wreckage from the 8 coronavirus. 9

Among their suggestions, the first is aimed to minimize the spread of the virus from 10 asymptomatic carriers, specifically with the use of universal precautions. However, the 11 recommendation for treating all patients who come to the hospital for surgery with universal 12 precautions is accompanied with the caveat that there is a presumption of adequate supplies. 1 13 This, of course, is a challenging assumption, as it will vary based on location, population density, 14 financial resources, and phase of the surge, among many additional variables. In order to heed 15 the advice provided here with regard to utilization of universal precautions, more work is 16 currently needed to explore the challenges as well as potential solutions for addressing critical 17 shortages of personal protective equipment (PPE). 3 18

Chen and colleagues go on to provide specific recommendations for common thoracic diseases, 19 which are overall quite helpful. While these recommendations are geared toward the general 20 thoracic surgeon, certainly, this is a time when similar guidance are being proposed to steer adult 21 and congenital cardiac surgeons, as well. 4, 5 In terms of disease processes, Chen recommends 22 cessation of operating for ground glass lesions; firstly, because ground-glass predominant 23 malignancies typically exhibit an indolent and favorable course, and second, due to challenges in 24 discerning COVID-related imaging findings from those of pure ground glass adenocarcinomas. 1 

With regard to N2-IIIA non-small cell lung cancer (NSCLC), Chen recommends consideration 26 of induction therapy to delay surgery or deferral to definitive chemoradiation followed by 27 immunotherapy, depending on additional patient factors. Moreover, for assessing stage of 28 NSCLC patients, we are urged to rely upon positron emission tomography, despite its inherent 29 limitations, to reduce additional procedures of endobronchial ultrasound and mediastinoscopy, 30 especially considering risk of aerosol generation with the former. For esophageal cancer, the 31 suggestion is made to consider, for select patients, bimodal rather than trimodal therapy, with the 32 caveat that salvage resection could potentially be offered as needed after the pandemic. Finally, 33

for patients with COVID-19 who require urgent or emergent surgical procedures, Chen and 34 colleagues urge us not to abandon our patients in the greatest need-but also not to forget the 35 importance of protecting ourselves and our teams with adequate PPE. These are all excellent 36 recommendations, and, for the large part, correspond with those recommendations made by the 37 Thoracic Surgery Outcomes Research Network (ThORN) regarding triage of operations for 38 thoracic malignancies during this pandemic. 6 39 However, one of the strengths of the ThORN consensus statement is that all recommendations 40 are based on the hospital's phase within the surge in terms of prevalence of COVID-19 patients 41 within the institution, availability of hospital resources, and rate of change. 6 While the advice 42 from Chen et al is outstanding, it does not take into consideration the various phases of the 43 pandemic that may be facing the readership. 1 In addition, one might note that many of the 44 recommendations made by Chen are based on less-than-robust oncological evidence; however, 45 this is actually very appropriate given that the recommendations are based on the best data that 46 we have available and guidance is in high demand during this challenging time. As stated by 47 infectious disease specialist Dr. Annie Antar, "All of us want to practice evidence-based 48 medicine, but the timeline for this might not allow us to wait for that." 7 49

Chen and colleagues have taken a humbling and altruistic approach, sharing information that will 50 be of great benefit to our thoracic surgical community. In times such as this, there exists much 51 uncertainty regarding best practices, outcomes, and consequences of the very challenging 52 decisions with which we are all faced. However, one thing is absolutely certain: such sharing of 53 experiences-successes, failures, and lessons learned-is imperative to enable us all to save as 54 many lives as possible. 55 56

Insights from China: Improving Thoracic 58

Surgery Outcomes During the COVID-19 Pandemic

Clinical course of coronavirus disease 2019 in 11 patients after 60 thoracic surgery and challenges in diagnosis

Challenges and solutions for addressing critical shortage of supply 62 chain for personal and protective equipment (PPE) arising from Coronavirus disease

pandemic -Case study from the Republic of Ireland

During the COVID-19 Pandemic

Triage Considerations for Patients Referred for 67

Structural Heart Disease Intervention During the Coronavirus Disease

Pandemic: An ACC /SCAI Consensus Statement

Thoracic Surgery Outcomes Research Network I. COVID-19 Guidance for Triage of 70

Operations for Thoracic Malignancies: A Consensus Statement from Thoracic Surgery Outcomes 71 Research Network

Desperate for Covid-19 answers, U.S. doctors turn to colleagues in China